Cargando…
Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain
Polo-like kinase 1 (Plk1) is a promising target for cancer therapy due to its essential role in cell division. In addition to a highly conserved kinase domain, Plk1 also contains a Polo-Box domain (PBD), which is essential for Plk1's subcellular localization and mitotic functions. We adopted a...
Autores principales: | Chen, Yunyu, Zhang, Jing, Li, Dongsheng, Jiang, Jiandong, Wang, Yanchang, Si, Shuyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352051/ https://www.ncbi.nlm.nih.gov/pubmed/27902479 http://dx.doi.org/10.18632/oncotarget.13603 |
Ejemplares similares
-
Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015) -
A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018) -
Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009) -
MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
por: Abdelfatah, Sara, et al.
Publicado: (2019) -
Development of a Novel Cell-Permeable Protein–Protein
Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase
1
por: Huggins, David J., et al.
Publicado: (2019)